Ending Parkinson's Disease: A Prescription for ActionIn this "must-read" guide (Lonnie Ali), four leading doctors and advocates offer a bold action plan to prevent, care for, and treat Parkinson's disease-one of the great health challenges of our time. Brain diseases are now the world's leading source of disability. The fastest growing of these is Parkinson's: the number of impacted patients has doubled to more than six million over the last twenty-five years and is projected to double again by 2040. Harmful pesticides that increase the risk of Parkinson's continue to proliferate, many people remain undiagnosed and untreated, research funding stagnates, and the most effective treatment is now a half century old. In Ending Parkinson's Disease, four top experts provide a plan to help prevent Parkinson's, improve care and treatment, and end the silence associated with this devastating disease. |
Contents
Six Men in London | |
A ManMade Pandemic | |
Vanquishing Indifference | |
Before It Starts | |
Cleaning | |
Within Our Reach | |
Disclosures | |
Praise for Ending Parkinsons Disease | |
Other editions - View all
Ending Parkinson's Disease: A Prescription for Action Ray Dorsey,Todd Sherer,Michael S. Okun,Bastiaan R. Bloem No preview available - 2020 |
Ending Parkinson's Disease: A Prescription for Action Ray Dorsey,Todd Sherer,Michael S. Okun,Bastiaan R. Bloem No preview available - 2020 |
Ending Parkinson's Disease: A Prescription for Action Ray Dorsey,Michael S. Okun,Todd Sherer,Bastiaan R. Bloem No preview available - 2021 |
Common terms and phrases
Accessed February Accessed June 28 Accessed March 29 Accessed November Agent Orange alpha-synuclein American Annals of Neurology Association Bloem Blog Braak breast cancer caffeine Camp Lejeune cause Center chemical chlorpyrifos clinical trial contaminated countries Davis Phinney deep brain stimulation develop Parkinson’s diagnosed Disease Registry dopamine Dorsey Ending Parkinson's Environmental Health Perspectives Environmental Protection Agency exposure factors FIGURE Fox Foundation funding gene genetic Global heptachlor human Ibid increased individuals JAMA Neurology June 28 Lancet Neurology Langston levodopa linked LRRK2 March 29 Medicare Michael million misfolded Movement Disorders MPTP mutations National nerve cells neurologist Neurology Neuroscience nursing home Okun pandemic paraquat Parkinson's disease Parkinson's Foundation Parkinson's research ParkinsonNet patients pesticides polio pollution protein rates risk of Parkinson Ross GW rotenone Science scientists smartphone smoking solvent substantia nigra Superfund symptoms therapies toxic treatment tremor trichloroethylene United Updated veterans Wikipedia York